Theoretical portfolio presents biomorphic and physico-chemical frameworks for autonomous biomedical systems, highlighting novel engineering paradigms for oncology, diabetes, and renal failure.
Dear Academic Community and Fellow Researchers, My name is Mohammed Hussein Mohammed Rashad, an independent pre-university researcher from Faiyum, Egypt. I have consolidated my complete research portfolio—comprising multiple individual technical specification files and research papers covering novel concepts in Oncology, Type-1 Diabetes Management, and Artificial Renal Systems—into this single unified Zenodo deposit. These files represent rigorous physico-chemical and biomorphic models designed to bypass conventional biological bottlenecks. I invite university professors, research laboratories, and oncology/pharmacology specialists to review these individual manuscripts and technical drafts. If you wish to collaborate, experimentally validate, or expand upon any of these projects, feel free to do so with proper citation and attribution. For potential academic collaborations, research inquiries, or project expansions, you can reach me directly via email at: ( [kmomo9890@gmail.com] )
No takes yet. Share an insight, caveat, or question.
Mohammed Hussein Mohammed Rashad (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: